SWOT Analysis for Immunovant Inc

MACD Crossover Above Signal Line
Positive Breakout Third Resistance ( LTP > R3)
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Companies with Low Debt
Positive Breakout (LTP > R1)
High Volume, High Gain
Top Gainers
Stock with Low PE (PE < = 10)
Volume Shockers
High Volume, High Gain

Promoter decreasing their shareholding
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Annual net profit declining for last 2 years
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter